Home/Filings/4/0001144204-18-037563
4//SEC Filing

Chen Jing 4

Accession 0001144204-18-037563

CIK 0001563665other

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 5:15 PM ET

Size

7.1 KB

Accession

0001144204-18-037563

Insider Transaction Report

Form 4
Period: 2018-06-29
Chen Jing
Director
Transactions
  • Conversion

    Series D Convertible Preferred Stock

    2018-06-29540 total
    Exercise: $2.00From: 2017-12-27Common Stock (27,000 underlying)
  • Conversion

    Common Stock

    2018-06-29+27,00036,000 total
Footnotes (2)
  • [F1]Shares of common stock received upon conversion of Series D Convertible Preferred Stock.
  • [F2]The shares of Series D Convertible Preferred Stock have no expiration date.

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother

Related Parties

1
  • filerCIK 0001727177

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:15 PM ET
Size
7.1 KB